BWB Posts Q3 Results as Call Buyers Step Back to Earth

Bridgewater Bancshares has just reported Q3 2026 earnings, and the post-print positioning story is the most interesting thing about the stock this week: the dramatic options swing that preceded the release has now settled, leaving the broader picture looking calm rather than charged.

The options market told a sharp story into the print. The put/call ratio collapsed to 0.50 over the past two sessions, nearly three standard deviations below its 20-day mean of 5.77, a level that had dominated the options market throughout September and October when puts ran well above five times the volume of calls. That reversal reflected a surge in call buying ahead of results. With the earnings now out and the stock up 1.4% on the day to $20.61, the question is whether that call demand was rewarded or simply reflected traders who had been too cautious for too long. The borrow market adds little drama. Short interest has continued its steady retreat, falling roughly 21% over the past month to 2.3% of the free float. Cost to borrow is 0.54%, and availability is extraordinarily loose at over 6,400% of short interest. There is no short squeeze pressure here. This is a stock where bears have been methodically exiting, not building.

The Street is uniformly constructive on BWB, and the bull case rests on a margin recovery story that has been playing out. The most recent analyst action came from Piper Sandler in late July, raising its target to $24 from $23 while keeping an Overweight. DA Davidson has held its Buy with a $22 to $24 target range through multiple check-ins this year. All three covering analysts rate the stock Buy or Overweight, with a consensus target of $24, implying roughly 16% upside from current levels. The bull case centres on NIM expansion from loan repricing, with approximately $743 million in loans scheduled to reset higher, NII growth of around 19% projected for 2026, and capital ratios improving, with TBV at $16.60 and CET1 at 9.6%. Bears point to concentrated commercial real estate exposure, slowing deposit growth, and operating expenses that remain elevated after a period of heavy hiring. The P/E multiple of around 10x and P/B just above 1x keep valuation modest but not obviously cheap relative to the credit risks embedded in a CRE-heavy Minnesotan commercial bank.

FDIC call report data, published by the Federal Deposit Insurance Corporation, adds texture on the balance sheet trajectory, though the lead relationship between this dataset and BWB's reported figures has not yet been tested. What the data does show is that net loans and leases rose for seven consecutive quarters through April 2026, and the bank reported its largest second quarter for total assets on record (since 2024), with total assets reaching $5.38 billion. These are facts about the bank's own filed regulatory data, not proxies. They suggest the growth trajectory entering Q3 was intact, though the pace of that growth, and how deposit and fee trends have moved in the most recent quarter, is now visible in the just-released results.

Institutional ownership is concentrated and broadly stable. Thrivent Financial remains the largest holder at around 7.9% of shares. BlackRock added 180,000 shares through September to reach 6.3%. Dimensional and Vanguard both added modestly. Two insiders, David Juran and Jerry Baack, each hold above 5% of shares and have filed 13G/A amendments; neither carries activist intent. Three other insider names trimmed positions through August and September, including a small open-market sale by the Chief Experience Officer in mid-September, though the 90-day net insider figure is pulled heavily negative by what appear to be larger earlier disposals. Director-level award grants were processed at quarter-end across the board, a routine compensation event that adds no directional signal. Among close peers, UCB was the week's standout, up 6.3%, while MCB and FBNC both gained around 3%. BWB's 1.2% weekly gain was modest by comparison, though the stock's 1.4% move on results day suggests the print was received without alarm.

The next scheduled earnings date is late January 2027, giving the market time to assess whether NIM expansion continued in Q3 and whether expense growth is finally moderating, the two variables the Street is watching most closely.